MedPath

Detection of (sub) clinical toxicity in irradiated vs. non-irradiated surgically treated esophageal cancer patients: a pilot study.

Completed
Conditions
cardiopulmonary dysfunction
toxicity heart/lung
10082206
10017990
Registration Number
NL-OMON44510
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

- Treated for EC with a curative resection between 2000 and 2012
- Age >= 18 years
- Written informed consent
- No signs of tumor recurrence or new other malignancies.

Exclusion Criteria

- Thoracic radiotherapy for indications other than EC.
- Contra indication for cardiac MRI, pacemaker, cochlear implants, metal not compliable with MRI.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>As this is an exploratory pilot study to determine the most suitable diagnostic<br /><br>tests for future studies, there will be several endpoints related to<br /><br>(sub)clinical cardiopulmonary dysfunction.<br /><br>Signs of myocardial ischemia, systolic or diastolic dysfunction, rhythm and<br /><br>valve disorders, pericardial effusion and fibrosis, myocardial fibrosis, focal<br /><br>wall motion disorders and coronary calcifications will be analyzed. The<br /><br>cardiopulmonary (dys)function in EC survivors treated with neo-CRT followed by<br /><br>surgical resection will be compared to cardiopulmonary (dys)function in EC<br /><br>survivors treated with surgical resection alone.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>-</p><br>
© Copyright 2025. All Rights Reserved by MedPath